The Supreme Court on Monday sought response from the Centre, the Drug Controller of India and others on a PIL seeking ban on manufacture, use and sale of the 5-in-1 Pentavalent vaccine, which inoculates for Hep B, diphtheria and tetanus in children.
A bench headed by Chief Justice P Sathasivam issued notice to the Centre, CMC Vellore and the DCI on a plea of senior doctor Yogesh Jain, who alleged that the vaccine has serious side-effects on children causing death of 21 minors so far in the country.
Meanwhile, another bench of the apex court also issued notice to the Centre on a PIL seeking full access to the research and information on the PATH project on Human Papillomavirus (HPV) vaccines that is used for preventing cervical cancer in India to Vellore based Christian Medical College.
Describing the HPV vaccines as unproven and hazardous, the PIL petitioner Kalpana Mehta said the anomalies in the safety and efficacy of the vaccine was brought out by the various women groups and health groups from across the country.
